- In March 2022, a study published on PubMed reported that, in a randomized open-label trial, the combination of corticosteroids with glycyrrhizin was evaluated for its efficacy in treating chronic liver injury induced by drugs or herbs. The results demonstrated significant biochemical and histological improvements, indicating that this combination therapy could be beneficial in managing liver fibrosis resulting from such injuries.
